GLP1 NAION warning: FDA orders class-wide labels for potential rare eye risk

Mga puntong iniulat ng higit sa isang outlet

1. FDA requirement for NAION warnings on GLP-1 labels3 outlet
2. NAION effects on vision2 outlet
3. Drugs covered by the FDA labeling requirement2 outlet
4. Evidence included in the FDA evaluation2 outlet